These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 16443393)

  • 1. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
    Miura P; Jasmin BJ
    Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic strategies for Duchenne and Becker dystrophies.
    Voisin V; de la Porte S
    Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
    Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S
    Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utrophin upregulation in Duchenne muscular dystrophy.
    Hirst RC; McCullagh KJ; Davies KE
    Acta Myol; 2005 Dec; 24(3):209-16. PubMed ID: 16629055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.
    Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S
    J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
    Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
    Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Utrophin, a way to cure Duchenne muscle dystrophy].
    Gillis JM
    Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
    Sundaram C; Vydehi B; Meena K; Murthy J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
    Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
    Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle.
    Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S
    J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB; Chamberlain JS
    Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
    Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
    D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
    Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice.
    Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C
    Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse.
    Gramolini AO; Wu J; Jasmin BJ
    Microsc Res Tech; 2000 Apr; 49(1):90-100. PubMed ID: 10757882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoA leads to up-regulation and relocalization of utrophin in muscle fibers.
    Gauthier-Rouvière C; Bonet-Kerrache A
    Biochem Biophys Res Commun; 2009 Jul; 384(3):322-8. PubMed ID: 19409875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy.
    Guiraud S; Edwards B; Babbs A; Squire SE; Berg A; Moir L; Wood MJ; Davies KE
    Hum Mol Genet; 2019 Jul; 28(13):2189-2200. PubMed ID: 30990876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
    Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE
    Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
    Judge LM; Haraguchiln M; Chamberlain JS
    J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.